Navigation Links
Diplomat Specialty Pharmacy Hires Vice President of Operations
Date:7/12/2010

SWARTZ CREEK, Mich., July 12 /PRNewswire/ -- Diplomat Specialty Pharmacy, the nation's largest privately owned specialty pharmacy, announced today that Robert Fleckenstein has joined the Company's executive team. Mr. Fleckenstein will serve as the Company's Vice President of Operations overseeing the day-to-day operations of Diplomat's National Distribution Center, Patient Service Operations, Call Center, Oncology Department and other patient facing services at Diplomat's Corporate headquarters. Because of Fleckenstein's prior work experience in management and pharmacy operations, he will be actively involved in the layout and development of Diplomat's new corporate headquarters, employee training, compliance and other executive management functions. Mr. Fleckenstein will report to Jeff Rowe, Sr. Vice President of Operations.

"We have complete confidence in Bob and feel very fortunate to have him join us," said Mr. Rowe. "His experience with National Operations and Patient Services is very important. As Diplomat grows nationally we will continue to do what we do best; provide the very best high touch care for patients who require high tech medications."

"It is a very exciting time for Diplomat Pharmacy and I am very pleased to be part of the team," said Mr. Fleckenstein. "As the individual responsible for operations at the new Great Lakes Biotech Center, I plan to develop the training modules and management tools that allow us to continue to grow efficiently and effectively without losing sight of the patient care model, and the culture, that has allowed us to reach this point."

Prior to joining Diplomat, Mr. Fleckenstein served as Vice President of Pharmacy Operations at Allion Healthcare Inc; Regional Manager, Oncology Pharmaceuti
'/>"/>

SOURCE Diplomat Specialty Pharmacy
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Southwest Oncology Network (SWON) Selects Diplomat Specialty Pharmacy for Development and Launch of SWON-Rx, an Oral Oncology Medication Management Platform
2. Diplomat Specialty Pharmacy Continues to Expand - Opens Location in Southern California
3. Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS)
4. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
5. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
6. Sagent Pharmaceuticals and Actavis Enter Into Exclusive U.S. Development, Supply and Marketing Collaboration for a Portfolio of Specialty Injectable Pharmaceutical Products
7. New Life Agency, Inc. Joins Forces With The Diamond Institute and Walgreens Specialty Pharmacy to Introduce the Nations First In Vitro Fertilization Insurance Program
8. Sarnova Announces Acquisition of CVC, Inc. to Expand Portfolio of Specialty Medical Products
9. American Imaging Managements New Specialty Drug Program Delivers Immediate Results
10. Echo Therapeutics to Present at the New York Society of Security Analysts 13th Annual Biotech and Specialty Pharmaceuticals Conference
11. Statement of Americas Specialty Medicines Companies On House Health Care Bill (H.R. 3962)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... 2014 financial results after the Nasdaq market closes on ... live conference call and webcast to discuss its financial ... 7, 2014 at 8:00 a.m. Eastern Time (5:00 a.m. ... conference call by dialing 866-952-1907 (US) or 785-424-1826 (International) ...
(Date:7/29/2014)... Research and Markets has announced the addition ... report to their offering. ... medical device used to provide medication or assist a ... achieve adequate oxygen levels to maintain life. Patients with ... ARDS require the need of respiratory devices. The medication ...
(Date:7/29/2014)... 2014 Cynosure, Inc. (Nasdaq: ... light-based aesthetic treatment systems for high-volume applications, today reported ... 2014. Second-quarter 2014 financial results incorporate the acquisition of ... 2013. Second-Quarter 2014 Financial Highlights ... $72.6 million , Non-GAAP net income of $7.1 ...
Breaking Medicine Technology:Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 2Global Respiratory Devices Market 2014-2018 2Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12
... Attached is a press release issued yesterday by GlaxoSmithKline (GSK), ... the American Diabetes Association 69th Scientific Sessions in New Orleans. ... ) , , Syncria is a biological product ... human GLP-1 peptide, and is designed to act throughout the ...
... , Oral Presentation Details Dose Optimization of Pre-Clinical ... 8 Tolerx, Inc., a biopharmaceutical company engaged ... for immune-mediated diseases, today presented results from a ... its Phase 3 anti-CD3 monoclonal antibody, otelixizumab, at ...
Cached Medicine Technology:FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight 2FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight 3Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 2Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 3
(Date:7/30/2014)... According to the Yeast Infection No More book review ... will help candida sufferers get rid of their yeast ... to readers the truth about yeast infection and the real ... will discover natural and safe remedies to relieve symptoms of ... irritation of the vagina or vulva. , Vkool reveals ...
(Date:7/30/2014)... July 30, 2014 My Clients ... over 80 different electronic therapy note templates. Healthcare ... and other computing devices all while meeting the ... or electronic medial records (EMR) consist of psychological ... other essential categories. SOAP and DAP note ...
(Date:7/30/2014)... July 30, 2014 Regents Health Resources, ... services, has brought health care industry veteran Daryl Demonbreun ... to help lead the company’s ambitious plans to grow ... Health has been moving along at a steady pace ... it up a notch,” says Bob Maier, founder and ...
(Date:7/29/2014)... July 30, 2014 Recently, iFitDress.com, a well-known ... of satin bridal gowns . Aside from this, it ... prices, up to 68 percent off. All of its old ... , The company’s sales representative says excitedly, “We are pleased ... the new range, there are a lot of amazing items. ...
(Date:7/29/2014)... Dignity Sciences Limited, a privately held biopharmaceutical company, ... trial with DS107G, an oral formulation of Dihomo Gamma ... placebo-controlled, double-blind, single-ascending and multiple dose Phase I clinical ... food on DS107G in healthy subjects. , The ... both single and multiple oral doses over 28 days, ...
Breaking Medicine News(10 mins):Health News:Yeast Infection No More Book Review Exposes Linda Allen's Guide for Treating Yeast Infection – Vkool.com 2Health News:Yeast Infection No More Book Review Exposes Linda Allen's Guide for Treating Yeast Infection – Vkool.com 3Health News:My Clients Plus Announces Over 80 Online Therapy Notes to Help Healthcare Providers Go Paperless 2Health News:Sferrella and Demonbreun Join Regents Health Resources 2Health News:Cheap Satin Bridal Gowns Recently Provided By Well-known Supplier iFitDress.com 2Health News:DS107G-01 – Successful Completion of Phase I Oral DGLA Clinical Trial 2
... Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) today announced ... Annual Healthcare Conference will be webcast,live and may ... the Company,s,website, http://www.millennium.com ., (Logo: ... an update on VELCADE(R) (bortezomib) for,Injection and product ...
... Precyse to a leadership role, in Health Information ... Costs ... Precyse Solutions, the leader in,driving peak performance within Health ... as Senior Vice,President and Chief Information Officer. Joining Precyse in ...
... Acute Pain Prescription Drug ... ... Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) today announced that it has begun ... product (study 06CCL3-001)., "Tramadol-acetaminophen combination products have become widely,prescribed based ...
... 8 a.m. EDT, SHENZHEN, China, March 10 /Xinhua-PRNewswire-FirstCall/ ... ("Nepstar" or "the Company"), the,largest drugstore chain in China ... that it will report financial results for the,fourth quarter ... market,opens on March 19, 2008., The Company will ...
... March 10 Tea-based ingredients are now ... Colorado-based Sage,Group(R), a self-described ,tea think-tank, notes ... outnumber beverage,tea offerings on a global basis. ... other tea derivatives are being formulated into,thousands ...
... March 10 On March 23, the Easter,Bunny will ... goodies.,But, if you,re one of the lucky recipients, make ... your pets. Chocolate is poisonous to,dogs and cats, and ... equally as dangerous., Dr. Gregory S. Hammer, president ...
Cached Medicine News:Health News:Cowen & Company 28th Annual Healthcare Conference to Webcast Millennium Presentation 2Health News:Precyse Solutions Promotes Ken Lacy to Senior Vice President & CIO to Drive Advancement of PrecyseNet(TM), Precyse's Advanced Technology Solution 2Health News:Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen 2Health News:Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen 3Health News:China Nepstar Chain Drugstore to Announce Fourth Quarter 2007 Financial Results on March 19 2Health News:China Nepstar Chain Drugstore to Announce Fourth Quarter 2007 Financial Results on March 19 3Health News:Tea Ingredients Publication Serves Robust Global Demand for Tea-Based Products 2Health News:Tea Ingredients Publication Serves Robust Global Demand for Tea-Based Products 3Health News:AVMA: Keep Pets Safe This Easter 2
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
25L...
This fixed-volume digital micropipet is used to accurately measure and transfer 50 microliters of solution....
50L...
Medicine Products: